AML Patients Relapse Post-Transplantation by Escaping Transferred Immune Cells

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-049
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Relapse After Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in AML/MDS: Monocyte Chemo-Attractant Protein-1 (MCP-1) Levels Post HCT and Prediction of Relapse in Patients With Hematological Remission and Full Chimerism at Day 30

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Impact of Pre-Transplant Measurable Residual Disease on Relapse Incidence and Progression-Free Survival in Older AML/MDS Patients Following Allogeneic Hematopoietic Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Post Transplantation High-Dose Cyclophosphamide (PTCy) to Promote Immune Tolerance After Reconstructive Transplantation

Vascularized Composite Allotransplantation
2014English

Sequential HLA-haploidentical Transplantation Utilizing Post-Transplantation Cyclophosphamide for GvHD Prophylaxis in High-Risk and Relapsed/Refractory AML/MDS

American Journal of Hematology
Hematology
2018English

Is Imatinib Maintenance Required for Patients With Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation

PLoS ONE
Multidisciplinary
2013English

The Evolving Roles of Memory Immune Cells in Transplantation

Transplantation
Transplantation
2015English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

Post-Relapse Survival in Diffuse Large B-Cell Lymphoma (DLBCL) Patients After Experiencing Therapy Failure Following Autologous Hematopoietic Cell Transplantation (Auto-Hct)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Monitoring of WT1 Expression in PB and CD34+ Donor Chimerism of BM Predicts Early Relapse in AML and MDS Patients After Hematopoietic Cell Transplantation With Reduced-Intensity Conditioning

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy